Tawazun Council for Defence Enablement is an independent UAE government entity working closely with the Ministry of Defence and security agencies. It focuses on strengthening the defence and security sector through capability development, innovative solutions, effective acquisition and development strategies, and support for national capabilities and local content. It also supports a regulatory environment that encourages technological innovation, investment and sustainable growth in the UAE’s defence and security industries.

Burjeel Holdings is a healthcare group focused on delivering world-class healthcare at scale. Its diversified portfolio covers healthcare brands and services, with a focus on complex medical care, advanced technology, experienced clinical teams and patient-centred care. The group places innovation, clinical excellence and compassionate care at the centre of its approach to raising healthcare standards.

EDGE is a UAE-based advanced technology group established in 2019 to develop agile and disruptive solutions for defence and beyond. Headquartered in Abu Dhabi, it brings together businesses across platforms and systems, missiles and weapons, space and cyber technologies, commercial solutions, technology and industrialisation, and homeland security. EDGE combines R&D, emerging technologies, digital transformation and commercial innovation with defence capabilities.

Gulf Drug is a UAE healthcare company established in 1969 and part of the Al Moosa Healthcare Group. It provides healthcare products and services across pharmaceuticals, consumer healthcare, medical equipment, medical supplies and veterinary care, and supports turnkey hospital projects. Its services also include pharmaceutical market access, regulatory and pharmacovigilance support, storage and distribution.

Exclusive Global Health Partner
M42 is a global health champion powered by artificial intelligence (AI), technology and genomics to advance innovation in health for people and the planet. Headquartered in Abu Dhabi, M42 combines its specialized, state-of-the-art facilities with integrated health solutions like genomics and biobanks, and harnesses advanced technologies to deliver precise, preventive and predictive care, to impactfully disrupt traditional healthcare models and positively impact lives globally.

Established in 2023, following the coming together of G42 Healthcare and Mubadala Health, M42 has more than 480 facilities in 26 countries and over 20,000 employees. M42 includes renowned healthcare providers, including Cleveland Clinic Abu Dhabi, Danat Al Emarat, Diaverum, Imperial College London Diabetes Centre, Sheikh Sultan bin Zayed Hospital, and Moorfields Eye Hospital Abu Dhabi. As well as operating the Emirati Genome Programme, M42 runs Abu Dhabi BioBank and Abu Dhabi Health Data Services (ADHDS), a global tech-enabled healthcare company operating Malaffi.

Mubadala Bio is a life sciences company wholly owned by Mubadala Investment Company and headquartered in Abu Dhabi. It focuses on improving health outcomes in the UAE and beyond through Integrated Biopharma and Pharma Logistics. The company supports local pharmaceutical manufacturing and distribution of essential medical therapies, while building partnerships, developing talent and contributing to the UAE’s life sciences ecosystem.

Dräger — Technology for Life. For more than 130 years, we have been an international leader in the fields of medical and safety technology. Whether in the operating room, in intensive care or emergency response services, our ventilation, anesthesia and patient monitoring solutions support medical teams around the world – including in military and humanitarian medicine. In the field, our respiratory protection and gas detection technology safeguards personnel in disaster response, humanitarian relief and hazardous environments. Founded in 1889, Dräger generated revenues of around €3.5 billion in 2025 and is present in over 190 countries with more than 16,000 employees worldwide. Our products protect, support, and save lives.

Experience Abu Dhabi is the destination brand of the Department of Culture and Tourism – Abu Dhabi. It promotes Abu Dhabi as a year-round destination by showcasing the emirate’s cultural heritage, leisure, entertainment, hospitality and other visitor experiences. The brand aims to inspire visitors to discover Abu Dhabi and experience its attractions, culture and destinations at their own pace.

Delegate Bag Sponsor
Gewan Investment is an Abu Dhabi-based investment and aviation company focused on cargo and logistics, aviation services and Hajj and Umrah travel solutions. It highlights innovation, reliability, safety and tailored solutions for airlines, airports and other businesses, while aiming to contribute to the UAE economy through innovation, local partnerships, sustainability and community engagement.

Lufthansa Technik is a global aviation technology and aircraft services company headquartered in Hamburg, Germany. It provides a broad range of aircraft services across the fleet life cycle, including maintenance, repair and overhaul, component services, aircraft modification, digital fleet support, cabin solutions and defence services. Its customers include airlines, lessors, governments and private aircraft owners.

Saudi German Health, Dubai is part of Saudi German Health, a leading private healthcare group with a growing network of medical facilities across the Middle East and North Africa. Founded by the Batterjee family, the group began its healthcare journey in 1988 and has established a strong presence in the UAE. Opened in 2012 as the first Saudi German Hospital in the UAE, Saudi German Hospital Dubai is a tertiary-care healthcare destination offering comprehensive medical and surgical services across a wide range of specialties and subspecialties. The Dubai branch is part of Batterjee Medical City and includes Saudi German Hospital Dubai, Saudi German Women & Children Specialty Hospital, and Saudi German Orthopedic & Trauma Hospital, supported by specialized clinics across Dubai. With a focus on patient-centered care, clinical excellence, innovation, and advanced medical technology, Saudi German Health aims to provide accessible, comprehensive healthcare while delivering a caring, family-oriented patient experience

SERB is a reliable partner specializing in CBRN medical countermeasures, with decades of experience supporting military forces, emergency preparedness organizations, and government stakeholders worldwide.

Our portfolio spans the complete CBRN survivability pathway, from immediate skin decontamination with RSDL to life-saving antidotes. Manufactured to pharmaceutical-grade standards, our solutions provide the quality, reliability, and operational confidence required in mission-critical situations.

From exposure to treatment, SERB delivers trusted solutions that enhance preparedness and survivability when it matters most.

Knowledge Partner
United Arab Emirates University is the UAE’s first comprehensive national university, founded in 1976. It is a research-intensive institution offering accredited undergraduate and graduate programmes across nine colleges. UAEU works with industry and other partners on research addressing national, regional and global challenges, while continuing to invest in education, research, facilities and innovation.

Access to dried plasma remains critically limited. Fewer than 50,000 units are produced globally each year, with manufacturing concentrated in only a small number of countries.

Velico is working to change this through its FrontlineODP™ Spray Dried Plasma Manufacturing System. Designed for use in blood centers, it enables decentralized production of shelf-stable spray dried plasma in flexible, ultra-lightweight PVC bags. The spray dried plasma can be rehydrated and ready for transfusion in 2.5 minutes, bringing it closer to patients in ambulances, helicopters, rural clinics and military settings.

Positive results from Velico’s Phase 1 safety trial showed that FrontlineODP™ was well tolerated across all dose levels, with a safety profile comparable to standard frozen plasma.

Velico has also developed the veliPod™, a modular, containerized decentralized manufacturing facility. Rapidly deployable without extensive pharmaceutical infrastructure or purpose-built clean rooms, it enables sovereign, scalable production at military bases, blood centers and other strategic or remote locations.

The first veliPod™, inaugurated at the French Armed Forces Blood Transfusion Centre in Clamart, France.

Velico’s new U.S. production facility will support up to 100,000 units annually, advancing the wider availability of spray dried plasma.

CAUTION: FrontlineODP™ has not received FDA or EU approval for any indication.

Visit Velico at Booth D02 to learn more.

ZOLL Medical develops and markets medical devices and software solutions designed to advance emergency care and improve patient outcomes. Its portfolio includes technologies for defibrillation and cardiac monitoring, CPR feedback, ventilation, therapeutic temperature management, data management, sleep-apnoea diagnosis and treatment, and other critical-care applications.